Ipratropium Bromide
Rank #269 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$45.4M
Total Cost
656,249
Total Claims
$45.4M
Total Cost
19,700
Prescribers
$69
Cost per Claim
213,021
Beneficiaries
934,881
30-Day Fills
$2,306
Avg Cost/Provider
33
Avg Claims/Provider
Share of Medicare Part D Spending
0.02%
of total Medicare Part D spending
$45.4M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $45.4M total
Top Prescribers of Ipratropium Bromide
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Jorge Sanchez-Masiques | Pulmonary Disease | Miami, FL | 803 | $395K |
| 2 | Jorge Sanchez-Masiques | Pulmonary Disease | Miami, FL | 6,388 | $252K |
| 3 | Ritesh Kalra | Internal Medicine | Fair Lawn, NJ | 397 | $215K |
| 4 | Carlos Alcala Marquez | Pulmonary Disease | San Juan, PR | 398 | $187K |
| 5 | Monica Rodriguez Gomez | Nurse Practitioner | Miami, FL | 218 | $124K |
| 6 | Ravinder Randhawa | Otolaryngology | Delray Beach, FL | 1,305 | $52K |
| 7 | Yoel Brito | Pulmonary Disease | Miami, FL | 101 | $50K |
| 8 | Salim Rizk | Pulmonary Disease | Towson, MD | 101 | $49K |
| 9 | Rolando Guerra Iglesias | Nurse Practitioner | Miami, FL | 97 | $47K |
| 10 | Edwin Schachter | Pulmonary Disease | New York, NY | 88 | $47K |
| 11 | Edgardo Cartagena Ayala | Pulmonary Disease | San Juan, PR | 95 | $46K |
| 12 | Aijaz Yazdani | Pulmonary Disease | Elizabethtown, KY | 80 | $45K |
| 13 | Gary Wright | Physician Assistant | Gilbert, AZ | 59 | $45K |
| 14 | Ramiz Elias | Internal Medicine | San Diego, CA | 89 | $43K |
| 15 | Steven Bello | Otolaryngology | Naples, FL | 917 | $41K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 266 | Darunavir (Prezista) | $46.0M | 21,793 |
| 267 | C1 Esterase Inhibitor (Haegarda) | $45.8M | 894 |
| 268 | Alectinib Hcl (Alecensa) | $45.7M | 2,686 |
| 269 | Ipratropium Bromide (Ipratropium Bromide) | $45.4M | 656,249 |
| 270 | Amantadine Hcl (Amantadine) | $45.2M | 173,840 |
| 271 | Insulin Nph Human Isophane (Humulin N) | $44.9M | 172,714 |
| 272 | Bosutinib (Bosulif) | $44.9M | 2,962 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology